NEW APPROACHES IN THE MANAGEMENT OF METHICILLINRESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
*Shahnooshi Javad F and Anita Dadollahi Sarab
ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft
tissue infections (SSTIs) are a growing issue worldwide with
significant economic impact. As a pharmacist, you should be familiar
with all the risk factors and treatment available now a day. A new
antibiotic, tedizolid phosphate, appears to be a reasonable alternative to
linezolid for the treatment of acute bacterial skin and skin structure
infections (ABSSSI): A short (6-day) course of tedizolid phosphate
was as effective as a 10-day course of linezolid with regard to both
early and sustained clinical responses. Recently, new and unusual
antibiotic compound has been extracted from a marine microorganism
found in sediments off the coast of California, researcher also found
that wearing gloves and gowns in intensive care units does not reduce
overall rates of acquiring Methicillin-resistant Staphylococcus aureus
(MRSA).
Keywords: new approaches, methicillin-resistant staphylococcus aureus, management, antibiotic, prevention.
[Download Article]
[Download Certifiate]